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Guoliang Yu1, Ye Liang1, Ziming Huang1,2, Deron W. Jones1, Kirkwood A. Pritchard Jr1 and Hao Zhang1*Erratum
After publication of this work [1], it was noted that there
was an error within Fig. 1. Within the graph of Fig. 1a,
the labels for PBS and KYC were inadvertently reversed.
The open circles should represent KYC, whereas the
filled circles should represent PBS. Figure 1 has been
corrected in the original article and is also included
correctly below.
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Fig. 1 KYC significantly reduced neurological deficit and brain infarct
size in mice subjected to MCAO. a Effects of KYC on neurological
severity scores during 7 days after MCAO. Top panel: Experimental
scheme; KYC (10 mg/kg/day) or PBS via i.p. was administrated
starting 1 h after reperfusion. Bottom panel: Neurological severity
scores of mice after MCAO (*p < 0.05, KYC vs. PBS group at same
time interval, nonparametric Mann–Whitney test); b Effect of KYC on
infarct size in mice 3 days after MCAO. Images of brain coronal
sections (20-μm thick, 1-mm interval from rostral to caudal) by cresyl
violet stain were shown; c Infarct volume (*p < 0.05, KYC vs. PBS
group, n = 5/group, t test)
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